|
⚲
|
| Keyboard |
| David Matias | |
|---|---|
| Firm | |
| Address | c/o Rxware, Inc 1313 North Market Street, Suite 1000 Wilmington, DE 19801 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Rxware Inc | 021-554698 | Director | 6.1 M of 6.7 M |
||
| Rxware Inc | 021-530841 | Director | 0.2 M of 1.2 M |
||
| Rxware Inc | 021-512543 | Director | 0.7 M of 1.0 M |
||
| ECTO Inc | 021-509869 | Director | 0.1 M of 0.5 M |
||
| ECTO Inc | 021-495299 | Director | 0.6 M of 0.8 M |
||
| ECTO Inc | 021-360813 | Director | 3.0 M of 3.4 M |
||
| Cryoocyte Inc | 021-277368 | Director | 5.5 M of 7.4 M |
||
| Ecurv Inc | 021-271701 | Director | 2.9 M of 3.0 M |
||
| Upriser Inc | 021-242049 | Director | 0.2 M of 0.8 M |
||
| Vodia Capital LLC | |||||
| Vodia Ventures Fund II LP | 021-351668 | Executive Officer | 5.8 M of 30.0 M |
6.0 M | |
| Vodia Ventures Fund I LP | 021-192748 | Executive Officer | 2.6 M of 15.0 M |
3.7 M | |
| VV-Cryoocyte Fund LP | 021-276575 | Executive Officer | 0.6 M | 0.8 M | |